Oracle acquires Phase Forward

Oracle has bought the healthcare and life sciences software company, paying at 30-percent premium for its services

Oracle said on Friday it will acquire Phase Forward, a healthcare and life sciences software provider, for $685m. Oracle, which is intensely focused on vertical-specific applications, said the deal will bolster its healthcare software line-up.

Phase Forward's software is delivered as a service. The company's Integrated Clinical Research Suite manages the drug submission development and safety processes from trial to submission to the Food and Drug Administration and other authorities.

Oracle paid $17 (£11) a share for Phase Forward, which closed on Thursday at $13.08 a share, marking the deal as a 30-percent premium. The purchase will help position Oracle for the healthcare IT boom. Phase Forward was showing some strong growth. In 2009, Phase Forward delivered revenue of $213.3m, up 25 percent from 2008. Net income was $8m.

For more on this story, see Oracle buys Phase Forward; Bolsters healthcare software on


You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
Subscription failed.
See All
See All